Review: taking Methotrexate preservative free and Quetiapine fumarate together


Summary

Drug interactions are reported among people who take Methotrexate preservative free and Quetiapine fumarate together. This review analyzes the effectiveness and drug interactions between Methotrexate preservative free and Quetiapine fumarate. It is created by eHealthMe based on reports of 351 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Methotrexate preservative free and Quetiapine fumarate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Methotrexate Preservative Free

Methotrexate preservative free has active ingredients of methotrexate. It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate preservative free 157 users)

Quetiapine Fumarate

Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. (latest outcomes from Quetiapine fumarate 4,809 users)

On Jul, 18, 2016

351 people who take Methotrexate Preservative Free, Quetiapine Fumarate are studied.


Number of reports submitted per year:

Methotrexate preservative free and Quetiapine fumarate drug interactions.

Drug effectiveness over time:

Methotrexate Preservative Free:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 81.0% - (9 of 11 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Quetiapine Fumarate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 75.0% - (3 of 4 people)
  • 6 - 12 months: 25.0% - (2 of 8 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Methotrexate Preservative Free:
  • female: 61.0% - (11 of 18 people)
  • male: 0.0% - (0 of 0 people)
Quetiapine Fumarate:
  • female: 43.0% - (7 of 16 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Methotrexate Preservative Free:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 80.0% - (4 of 5 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 77.0% - (7 of 9 people)
  • 60+: 0.0% - (0 of 0 people)
Quetiapine Fumarate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (4 of 4 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 11.0% - (1 of 9 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • weight increased
  • depression
  • sinusitis
  • conversion disorder
  • depressed mood
  • drug ineffective
  • dysphonia
  • emotional distress
  • mania
  • partial seizures with secondary generalisation
1 - 6 months:
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic coma
  • diabetic neuropathy
  • type 2 diabetes mellitus
  • weight decreased
  • back pain
  • blood cholesterol increased
  • blood potassium decreased
  • blood triglycerides increased
6 - 12 months:
  • alveolitis
  • transaminases increased
  • psychotic disorder
  • headache - mixed tension migraine
  • lightheadedness - dizzy
  • nausea
  • vomiting
  • abdominal pain
  • dyspnoea
  • gamma-glutamyltransferase increased
1 - 2 years:
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • blood triglycerides increased
  • hyperlipidaemia
  • obesity
  • diabetes mellitus
  • hyperglycaemia
  • neuropathy peripheral
  • back pain
  • blood potassium decreased
2 - 5 years:
  • fatigue
  • depression
  • diabetes mellitus
  • pneumonia
  • arthralgia
  • cerebrovascular accident
  • death
  • diabetic complication
  • dizziness
  • hypertension
5 - 10 years:
  • obesity
  • diabetes mellitus
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • blood triglycerides increased
  • headache - mixed tension migraine
  • hyperglycaemia
  • hyperlipidaemia
  • lightheadedness - dizzy
  • neuropathy peripheral
10+ years:
  • burning mouth syndrome
  • excessive skin
not specified:
  • pain
  • anxiety
  • nausea
  • diabetes mellitus
  • arthralgia
  • rheumatoid arthritis
  • vomiting
  • depression
  • fatigue
  • back pain

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • diabetes mellitus
  • vomiting
  • fatigue
  • rheumatoid arthritis
  • arthralgia
  • depression
  • back pain
male:
  • death
  • diabetes mellitus
  • pancreatitis
  • abscess
  • pain
  • type 2 diabetes mellitus
  • oedema peripheral
  • unresponsive to stimuli
  • asthenia
  • difficulty in walking

Most common drug interactions by age *:

10-19:
  • cerebrovascular accident
  • death
  • diabetic complication
  • hypoglycaemia
  • type 2 diabetes mellitus
  • abdominal pain upper
  • asthenia
  • cholecystitis
  • cholecystitis chronic
  • gait disturbance
20-29:
  • abdominal pain
  • crohn's disease
  • vulvovaginal pain
  • anal abscess
  • infection
  • death
  • diabetes mellitus
  • hypoglycaemia
  • intestinal obstruction
  • acute respiratory distress syndrome
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • nausea
  • diabetes mellitus inadequate control
  • diabetic coma
  • diabetic neuropathy
  • weight decreased
  • vomiting
  • back pain
  • blood cholesterol increased
40-49:
  • anxiety
  • rheumatoid arthritis
  • nausea
  • depression
  • neuroleptic malignant syndrome
  • pain
  • hypoaesthesia
  • vomiting
  • abdominal pain
  • pneumonia
50-59:
  • pain
  • diabetes mellitus
  • somnolence
  • depression
  • fatigue
  • hyperlipidaemia
  • insomnia
  • diabetic neuropathy
  • diabetes mellitus inadequate control
  • drug ineffective
60+:
  • alveolitis
  • transaminases increased
  • psychotic disorder
  • nausea
  • pancytopenia
  • dizziness
  • dyspnoea
  • fall
  • arthralgia
  • cardiac failure congestive

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Methotrexate preservative free and Quetiapine fumarate?

Can you answer these questions?

More questions for: Methotrexate preservative free, Quetiapine fumarate

You may be interested in these reviews

More reviews for: Methotrexate preservative free, Quetiapine fumarate

On eHealthMe, Methotrexate preservative free (methotrexate) is often used to treat rheumatoid arthritis. Quetiapine fumarate (quetiapine fumarate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.